RE: Question you should be asking how did tiny VELA get to take part26 Oct 2020 21:00
EG : so if its re-licensed or sold for £100m VELA is could get 8% of (100m, minus 19.2m, minus sums payable to the major pharmaceutical company and certain funders, and provision for taxation (no idea on this figure, say just £10m for the example))
£100m - £29.2m = £70,800,000 * 8% = £5,664,000 payable to VELA.
So for an investment cost of £2,350,000 VELA would only make make £3,3140,000 profit on a £100m sale?
(even if the "sums payable to the major pharmaceutical company and certain funders, and provision for taxation" was £0 the 8% on £100m sale would be £6,464,000 / return of £4m profit)
Based on the 8% i would hope for atleast a £200-300m sale in the end to make it worth while on a risk / reward basis but for a potential quick turn around accelerated project <12 months even a £100m sale would be a tidy return on investment if they repurchased the shares issued to fund it in the first place.
Im just using the above as an example, any guesses on what it could actually be worth if it works as indicated so far?
"Under the terms of the Agreement, pursuant to either commercialisation route for the Asset, SGS will pay Vela 8 per cent. of proceeds received by SGS in excess of £19.2 million and after deduction of sums payable to the major pharmaceutical company and certain funders, and provision for taxation (the "Economic Interest"). Vela's Economic Interest shall be renegotiated should SGS receive further funding from third parties in the future."